Show simple item record

dc.contributor.authorKrol, Alexandra
dc.contributor.authorLopez Huerta, Violeta
dc.contributor.authorCorey, Taylor E. C.
dc.contributor.authorDeisseroth, Karl
dc.contributor.authorTing, Jonathan Thomas
dc.contributor.authorFeng, Guoping
dc.date.accessioned2020-08-17T21:03:27Z
dc.date.available2020-08-17T21:03:27Z
dc.date.issued2019-02
dc.identifier.issn1662-5110
dc.identifier.urihttps://hdl.handle.net/1721.1/126636
dc.description.abstractDopaminergic and serotonergic neurons modulate and control processes ranging from reward signaling to regulation of motor outputs. Further, dysfunction of these neurons is involved in both degenerative and psychiatric disorders. Elucidating the roles of these neurons has been greatly facilitated by bacterial artificial chromosome (BAC) transgenic mouse lines expressing channelrhodopsin to readily enable cell-type specific activation. However, corresponding lines to silence these monoaminergic neurons have been lacking. We have generated two BAC transgenic mouse lines expressing the outward proton pump, enhanced ArchT3.0 (eArchT3.0), and GFP under control of the regulatory elements of either the dopamine transporter (DAT; Jax# 031663) or the tryptophan hydroxylase 2 (TPH2; Jax# 031662) gene locus. We demonstrate highly faithful and specific expression of these lines in dopaminergic and serotonergic neurons respectively. Additionally we validate effective and sensitive eArchT3.0-mediated silencing of these neurons using slice electrophysiology as well as with a well-established behavioral assay. These new transgenic tools will help expedite the study of dopaminergic and serotonergic system function in normal behavior and disease.en_US
dc.description.sponsorshipNational Institute of Neurological Disorders and Stroke (Grants R01NS098505 and R21NS079992)en_US
dc.description.sponsorshipSimons Foundation (Grant 307913)en_US
dc.description.sponsorshipNational Institute of Mental Health (Grant R01MH099647)en_US
dc.description.sponsorshipNational Institute on Drug Abuse (Grant P50DA042012)en_US
dc.description.sponsorshipDefense Sciences Office (Contract W911NF-14-2-0013)en_US
dc.language.isoen
dc.publisherFrontiers Media SAen_US
dc.relation.isversionofhttp://dx.doi.org/10.3389/fncir.2019.00004en_US
dc.rightsCreative Commons Attribution 4.0 International licenseen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceFrontiersen_US
dc.titleTwo eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neuronsen_US
dc.typeArticleen_US
dc.identifier.citationKrol, Alexandra et al. "Two eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neurons." Frontiers in Neural Circuits 13 (February 2019): 4 dx.doi.org/10.3389/fncir.2019.00004 © 2019 The Author(s)en_US
dc.contributor.departmentMcGovern Institute for Brain Research at MITen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.relation.journalFrontiers in Neural Circuitsen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2019-10-01T12:47:15Z
dspace.date.submission2019-10-01T12:47:20Z
mit.journal.volume13en_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record